Uncategorized

Anti-obesity medications that target the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors represent a significant advance in the management of obesity and type 2 diabetes. These medications work by mimicking naturally occurring gut hormones that regulate appetite, slow gastric emptying, and improve insulin sensitivity. How These Medications Work GLP-1 and GIP are incretin […]